Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
04/2000
04/05/2000CN1249687A Compositions and methods for reducing ocular hypertension
04/04/2000US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors
04/04/2000US6046340 Imidazole containing pseudodipeptide product and compositions containing the same
04/04/2000US6046331 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
04/04/2000US6046232 α-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
04/04/2000US6046223 Treatment of macular edema
04/04/2000US6046204 Treatment of immunosuppressive, autoimmune, inflammatory, proliferative and hyperproliferative diseases including cancer, and of cutaneous manifestations of immunologically mediated diseases, for example rheumatoid arthritis, lupus
04/04/2000US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia
04/04/2000US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae
04/04/2000US6046009 Diagnosis and treatment of glaucoma
03/2000
03/30/2000WO2000017644A1 Ndp
03/30/2000WO2000017371A1 Polynucleotide constructs and uses thereof
03/30/2000WO2000017358A2 Human chaperone proteins
03/30/2000WO2000017357A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/30/2000WO2000017222A1 31 human secreted proteins
03/30/2000WO2000017203A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000WO2000017202A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000WO2000017195A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000WO2000017191A2 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000WO2000017190A2 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000WO2000016781A1 Chk1 kinase inhibitors
03/30/2000WO2000016767A1 Hydroxamate-containing cysteine and serine protease inhibitors
03/30/2000WO2000016761A2 Serotonergic 5ht2 agonists for treating glaucoma
03/30/2000WO2000016603A2 Bridged heterocyclic derivatives
03/30/2000WO1998053846A9 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
03/30/2000CA2344390A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/30/2000CA2344376A1 Bridged heterocyclic derivatives
03/30/2000CA2344262A1 4-aminopyrrolopyrimidines as kinase inhibitors
03/30/2000CA2344249A1 Pyrrolopyrimidines as protein kinase inhibitors
03/30/2000CA2344224A1 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
03/30/2000CA2344223A1 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them
03/30/2000CA2344150A1 Serotonergic 5ht2 agonists for treating glaucoma
03/30/2000CA2344100A1 31 human secreted proteins
03/30/2000CA2343353A1 Methods and compositions relating to egf-repeat-containing polypeptides
03/29/2000EP0988295A1 Heterocyclic substituted piperidines and uses thereof
03/29/2000EP0735868B1 Use of non-steroidal cyclooxygenase inhibitors for the manufacture of a medicament for the treatment of elevated intraocular pressure
03/29/2000CN1248971A Quinoxalinediones
03/29/2000CN1248911A Opthalmic non-irritating iodine medicament and method
03/29/2000CN1050839C Sulfonylamino pyrimidines compounds, medicinal composition containing same, its preparation process and use
03/28/2000US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes
03/28/2000US6043237 Use of photodynamic therapy for prevention of secondary cataracts
03/28/2000US6043221 Method for preventing and treating hearing loss using a neuturin protein product
03/28/2000CA2126086C Imidazoylalkyl substituted with a six membered nitrogen containing heterocyclic ring
03/23/2000WO2000015822A1 Methods for treatment of degenerative retinal diseases
03/23/2000WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000WO2000015797A2 Compositions and methods for the treatment of immune related diseases
03/23/2000WO2000015794A1 Human cell junction pdz protein
03/23/2000WO2000015793A2 Human gpcr proteins
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015775A1 Rnase p polypeptides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015614A1 Novel compounds
03/23/2000WO2000015609A1 Azetidine derivatives, preparation and medicines containing them
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015234A1 Compositions comprising corticosteroids for treating sinusitis or otitis media
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015226A1 Antihistamines for treating non-infective sinusitis or otitis media
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015206A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
03/23/2000WO2000006135A3 Cholinergic agents in the treatment of presbyopia
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000DE19910654A1 Calcium and magnesium-free infusion solution for macular surgery, having improved retina loosening effect
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000CA2346262A1 Methods for treatment of degenerative retinal diseases
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342833A1 Human gpcr proteins
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342301A1 Human cell junction pdz protein
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2341440A1 Novel compounds
03/22/2000EP0987917A1 Method of cell data transmission, cell, communication system and corresponding network terminal unit
03/22/2000EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000EP0986408A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986392A1 Method of treating chronic progressive vascular scarring diseases
03/22/2000CN1248262A 16-hydroxy-11-(substituted phenyl)-estra-4,9-diene derivatives
03/22/2000CN1050514C Antiallergic composition for ophthalmic or nasal use
03/21/2000US6040451 Used as analgesic, sedative and anaesthetic agents
03/21/2000US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base
03/21/2000US6040343 Remedy for keratoconjunctival diseases
03/21/2000US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use
03/21/2000US6040326 3-deoxyglucosone production inhibitor
03/21/2000US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal
03/21/2000US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides
03/21/2000US6039949 Plant extracts obtained by filtration, centrifuging and dialysis
03/21/2000US6039943 Removal of blood from vitreous humor of blood
03/21/2000CA2146097C 1h-indole-3-glyoxylamide spla2 inhibitors
03/16/2000WO2000014097A2 Novel pyranoses
03/16/2000WO2000013692A1 Ophthalmic compositions and process of using
03/16/2000WO1999067363A9 Ependymal neural stem cells and method for their isolation
03/16/2000WO1999059499A3 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
03/16/2000CA2342855A1 Novel pyranoses
03/16/2000CA2341325A1 Method of stimulating prosaposin receptor activity
03/16/2000CA2308472A1 Ophthalmic compositions and process of using
03/15/2000EP0985414A2 Method of treating glaucoma and ischemic retinopathy
1 ... 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 ... 531